about
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancerNanocarriers for diagnosis and targeting of breast cancerSynthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functionssiRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cellsMultifunctional materials for bone cancer treatment.Frontiers in cancer nanomedicine: directing mass transport through biological barriersA Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.Tumour-associated carbohydrate antigens in breast cancer.USNCTAM perspectives on mechanics in medicine.Nanocarriers for nitric oxide delivery.Nanotechnology for energy-based cancer therapiesA dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens.Physiologically relevant oxidative degradation of oligo(proline) cross-linked polymeric scaffoldsVarious types and management of breast cancer: an overviewDevelopment, characterization, and in vitro evaluation of tamoxifen microemulsions.Nanostructured porous Si-based nanoparticles for targeted drug deliveryLipid-based nanoparticles in cancer diagnosis and therapy.Advances in novel drug delivery strategies for breast cancer therapy.Nanoparticulate carriers: an emerging tool for breast cancer therapy.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs.Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines.Therapeutic application of injectable thermosensitive hydrogel in preventing local breast cancer recurrence and improving incision wound healing in a mouse model.Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems.Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy.Temperature-Sensitive Gold Nanoparticle-Coated Pluronic-PLL Nanoparticles for Drug Delivery and Chemo-Photothermal Therapy.Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment.Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.Nanoparticles of Conjugated Methotrexate-Human Serum Albumin: Preparation and Cytotoxicity EvaluationsSynthesis, Characterization, andIn VitroDrug Delivery Capabilities of (Zn, Al)-Based Layered Double Hydroxide NanoparticlesWhat Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near Future
P2860
Q24657308-014E716E-BFA0-4B01-8C95-3239104B3346Q26862309-AEE82CE3-6066-4964-97CB-EC1897FF702BQ30543404-5B632B7E-7C32-451E-9169-BCEE20B9FC15Q33439232-E9EB1DE4-41F0-468A-A3BB-7A8E7435DB37Q33709363-C9E3BACE-2786-4CED-8F58-7D879A0CB73DQ33746335-A15D6718-05DF-4398-88BF-E84F6630E919Q33949801-E91DD9B6-9480-4A0B-ADC1-87D322E83444Q34048052-515FFE55-7393-4ED3-B61C-434F46846C9EQ34398830-57B18A6E-EAF6-432E-A2F1-35DF81F638FBQ35176430-33C739A7-A354-44E8-B20D-D7520B93A4A1Q35264028-897D3812-0A6B-40C4-A8E6-089C9E6F9FCFQ35574714-9648C991-9074-4899-A3DD-9EB12B97F1D6Q35612959-F374E44B-6160-4A52-9D2C-8675CC515872Q35664703-ADF8B4FF-8DEC-4D94-87C8-E5197A94DB50Q35681427-5C6D7216-0258-4996-B3BD-6295ECC98C63Q36597461-083C69A6-39CA-462C-8A34-496BA3F426EAQ37052002-819E8520-4B1C-449E-A9F9-FFC88FFEDB41Q37777142-4E95A37A-A0B4-4675-8D64-5D6A740BDBE8Q38250517-3C8EEA78-6D89-4001-A0A0-D14EEF2A5894Q38597794-E9AB34DD-9A09-43DC-AC20-E5341E31D77CQ38689014-794796BB-D45F-434A-8018-0C2DCF6A3B75Q38768444-51209501-D64E-4C46-A697-8E190D582761Q38885180-56749348-982E-4347-A8B0-E29D88A64276Q39096986-F7CE77B1-0714-4CCD-B584-A8DDCD7BB22CQ39300505-FFB80051-43AF-4D9E-8CE6-765D54331E8CQ39411175-22F7FC92-9491-4AE4-A173-9D36B9E30BA3Q39470022-1BB862E9-1AF4-4904-9E0B-9083A0CB75EDQ47143050-9623BA6A-DA5F-4B1D-8088-87B8EED6C704Q50072050-132CD818-03B8-4FF8-8479-A58E7626089BQ50540368-1BC9E654-A2F9-4B58-9DE2-9C32C1EC037FQ53614518-EAA8EB72-6F87-4BC7-9234-A7D910BD34DFQ58691124-3B39B016-6B57-48C8-AB88-D15C536971AFQ59114146-E2662B47-72E4-4447-85D4-C07F08E74B71Q59128232-E5C834B0-866E-469F-A615-695A529A462B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanotechnology for breast cancer therapy.
@en
Nanotechnology for breast cancer therapy.
@nl
type
label
Nanotechnology for breast cancer therapy.
@en
Nanotechnology for breast cancer therapy.
@nl
prefLabel
Nanotechnology for breast cancer therapy.
@en
Nanotechnology for breast cancer therapy.
@nl
P2093
P2860
P1476
Nanotechnology for breast cancer therapy.
@en
P2093
Ennio Tasciotti
Fredika M Robertson
Jason H Sakamoto
Massimo Cristofanilli
Mauro Ferrari
Paolo Decuzzi
Takemi Tanaka
P2860
P2888
P356
10.1007/S10544-008-9209-0
P407
P577
2009-02-01T00:00:00Z